Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance. [electronic resource]
- Journal of virology Mar 1998
- 2416-21 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0022-538X
10.1128/JVI.72.3.2416-2421.1998 doi
Drug Resistance, Microbial--genetics Genes, env--drug effects Genetic Variation HIV Infections--blood HIV Protease Inhibitors--therapeutic use HIV-1--drug effects Humans Nelfinavir--therapeutic use Ritonavir--therapeutic use Viremia